晶云星空晶云星空

We provide oral formulation CDMO services for global clients

Crystal Formulation Services provides contract formulation development and manufacturing services for innovative drug products from preclinical, clinical to commercial stages. We offer one-stop shop from bulk manufacturing to packaging, labeling, storage and distribution. Our cGMP facility and QMS meet the FDA, EMA, and NMPA regulatory requirements.

Competitive Advantages

Technical Strength

• A strong technical team with >20 years of experience of delivering 100+ early phase and 19 commercialized products at global pharma

• Molecule-material-medicine (MMM) driven formulation strategy

• Expertise on enabling formulation development

• Specialize in mini-tablet pediatric formulation

• QbD-based versatile and strong agile manufacturing capability

Equipment and Instrument Strength

• Top of the line equipment and notch instruments for DS/DP characterization and formulation technology

Systems Strength

• cGMP facility and QMS that met NMPA, FDA, and EMA regulatory requirements

• One-stop shop from preclinical to commercial manufacturing

• Integrated clinical formulation development process from bulk manufacturing to packaging and supply

Platform Strength

• Leverage all business units within Crystal Pharmatech

Technical Strength
Equipment and Instrument Strength
Systems Strength
Platform Strength

Core Technology Platform

Mini Tablet
Formulation Development for Poorly Water-Soluble Drugs
Conventional Oral Solid Dosage Forms

News

more >
Crystal Formulations Services(CFS) Accelerated Clinical Manufacturing of Jacobio's p53 Y220C Activator and Supported Early Patient Enrollment and Dosi

Crystal Formulations Services(CFS) Accelerated Clinical Manufacturing of Jacobio's p53 Y220C Activator and Supported Early Patient Enrollment and Dosing

2024.07.26
Crystal Formulations Services Supported Accro Bioscience’s (Accropeutics) AC-201 Phase II Clinical Trial in China, Completing First Patient Dosing

Crystal Formulations Services(CFS) Supported Accro Bioscience’s (Accropeutics) AC-201 Phase II Clinical Trial in China, Completing First Patient Dosing

2024.05.06
Crystal Formulations Services(CFS) Successfully Passed the EU QP Audit

Crystal Formulations Services(CFS) Successfully Passed the EU QP Audit

2024.01.10
Crystal Formulation Services Successfully Passed the GMP & GDP Inspection Conducted by SGS

Crystal Formulation Services (CFS) successfully obtained certifications in both Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) from SGS

2023.11.01
Crystal Formulation Services Recognized as "Best Partner" by Allorion Therapeutics for Their Excellent Services

Crystal Formulation Services Recognized as "Best Partner" by Allorion Therapeutics for Their Excellent Services

2023.05.30
GMP Manufacturing Facility Successfully Passed the Remote Audit by a US Client, Marking a Key Milestone for Its global Quality Management System

Crystal Formulation Services' GMP Manufacturing Facility Successfully Passed the Remote Audit by a US Client, Marking a Key Milestone for Its global Quality Management System

2023.04.14
Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability

Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability

2023.01.19
Crystal Formulation Services, Formulation Tailor-made for Your Molecules

Crystal Formulation Services, a Technology-driven Formulation CDMO

2022.06.30
Dr. Xiaoxia Chen Joins Crystal Formulation Services as Chief Technology Officer

Suzhou,June 1, 2022 – Crystal Formulation Services, a technology-driven oral formulation CDMO and subsidiary of Crystal Pharmatech...

2022.06.01
​Crystal Formulation Services(CFS)Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China

CFS opens new Formulation Development Center and Analytical R&D lab in Suzhou,China.

2022.05.29

Join CFS

Let's make a difference at CFS!

Learn more